• Home
  • Search Results

Search Results

2779 studies match your search
Open

Drug that may help Cutaneous Lupus Erythematosus

Do you have Cutaneous Lupus Erythematosus (CLE)? If you have tried antimalarials but they haven't helped your skin get better, you may be able to take part in a research study. In this study, we want to find out if a new drug improves the skin of patients with CLE. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Bones, Joints, Muscles
  • Chronic Conditions
  • Skin, Hair, and Nails
Not currently enrolling

Gender and Autism Project

The goal of this study is to create a support group and resources for adolescents who identify as both autistic and gender diverse using input from adolescents, parents, and professionals.

Age & Gender
  • 10 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Child and Teen Health
  • LGBTQIA+
  • Mental and Emotional Health
  • Parents of Children
Visit Location
100% Remote (online, phone, text)
Open

Study of Oral Epetraborole for the Treatment of M. Avium Complex (MAC) Disease

Are you currently diagnosed with an M. Avium Complex (MAC) infection of your lungs? Have the treatments you received not improved your condition? If so, you may be eligible for a research study to learn if a new medication (Epetraborole) is safe and effective in treating this disease. Monetary compensation will be provided to all participants.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Immune System/Infections
  • Lungs and Breathing
  • Microbiome
  • Rare Diseases
Not currently enrolling

Psychiatric provider perspectives on genetic testing

The purpose of this study is to understand the psychiatric provider's perspective on genetic testing for psychiatric and mental health disorders

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Brain, Head, Nervous System
  • Genetics and Genetic Disorders
  • Opinions and Perceptions
Visit Location
100% Remote (online, phone, text)
Open

Sitting Interruption Study

Do you have cardiovascular disease risk factors? Do you sit too much? Help researchers learn more about the most effective strategy for interrupting sitting! If you are 45 years or older, you may be able to take part in a research study to find out if interrupting sitting with walking or pedaling reduces cardiovascular disease risk.

Age & Gender
  • 45 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Aging
  • Blood Pressure
  • Diabetes
  • and 9 more
Not currently enrolling

Type 1 Diabetes Inhaled Insulin Study

In this study, we want to learn more about the safety and effectiveness of inhaled insulin and continuous glucose monitor (CGM) use compared to usual care for people with type 1 diabetes.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Diabetes
Open

Nutrition for Precision Health - Tailored Nutrition Study

Nutrition is not one-size-fits-all. Nutrition, or the foods we eat, can help prevent and fight conditions such as high blood pressure, diabetes, stroke, and more. However, we all live in different environments, we come from different cultures, and each of us is starting from a different place with our health. Additionally, everyone breaks down food differently. Join the Nutrition for Precision Health research study to help researchers learn how our genes, cultural backgrounds, and environments affect our bodies' responses to food. Compensation provided.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Healthy Volunteer or General Population
Open

An Open-label, Multicenter Study of LOXO-435 in Advanced Solid Tumor Malignancies with FGFR3 Alterations

Have you been diagnosed with cancer and either your cancer did not respond to treatment or your cancer progressed? If so, you may be able to take part in a research study evaluating the safety of an investigational treatment called LOXO-435 in cancer patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Bladder, Other Cancers)
Open

A Phase 3 Trial in Metastatic Untreated Renal Cell (Kidney) Cancer [Nivolumab and Ipilimumab Followed by Nivolumab vs. Cabozantinib with Nivolumab]

Have you been diagnosed with Kidney Cancer? If so, you may be able to take part in a research study comparing a drug called cabozantinib to another treatment after receiving standard of care treatment in patients.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Kidney)
  • Kidneys and Liver
Open

ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer

Do you have endometrial cancer? ]. If so, you may be able to take part in a research study looking at the safety of giving a combination treatment of the drugs ONC201 plus Atezolizumab to patients with endometrial cancer.

Age & Gender
  • 18 years ~ 99 years
  • Female
Study Interest
  • Cancer (Uterine (endometrial))
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research